It is tempting to try to restore blood pressure to previous levels in this condition, to avoid early rebleeding, but, as with acute ischemic stroke, it is recommended that cautious lowering of blood pressure be carried out only in patients with extreme hypertension. The natural tendency is for elevated blood pressure to decline within a few days after stroke. Therefore the risk of causing harm by pharmacological lowering of blooc pressure, together with the lack of evidence ofassociatec benefit, suggests that it is wise not to treat high blooc pressure during the acute phase of stroke, unless there an comorbid conditions that could require antihypertensive treatment. The scientific basis for treatment decisions. The patient is not overweight and there is no evidence of target organ damage.
Routine laboratory tests including plasma cho-lesterol and glucose levels, are normal.
With aging central arteries progressively stiffen. Arterial alterations in hyperten-sion with a disproportionate increase in systolic over diastolic pressure. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The patient still lives with his wife at home, his capacity for independent activity being sufficiently preserved. The patient has no complaint.